BCL2 and ovarian carcinoma: In ovarian cancer (IOSE144, A2780, OVCAR3, and SK-OV-3) cells, dihydroartemisinin downregulates Bcl-2 and upregulates Bax, which inhibits cancer cell proliferation and leads to cell cycle arrest at the S phase [104, 147, 148].